Top 15 Biotechnology Angel Investors in Switzerland (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Penny Schiffer
Angel
|
4 | Switzerland, Germany, United Kingdom | Seed, Series A | Health Care, Medical, Finance | $533k–$8.9M |
|
Beat Schillig
Angel
|
1 | Switzerland | Seed, Series A | Information Technology, SaaS, Music | $2.2M–$5.1M |
|
Tej Tadi
Angel
|
1 | Switzerland | Seed | Robotics, Neuroscience | |
|
Patrick Delarive
Angel
|
1 | Switzerland | Seed | Security, Wireless, Wearables | |
|
Reinhard Ambros
Angel
|
1 | United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | |
|
Ulf Claesson
Angel
|
1 | Switzerland | Seed | Biotechnology, Food and Beverage | |
|
Alexsis de Raadt-St. James
Angel
|
1 | United States, Switzerland, United Kingdom | Seed, Series A, Series B | Software, SaaS, Health Care | $250k–$24M |
|
Emily Leproust
Angel
|
1 | Switzerland | Seed | Biotechnology, Product Research | |
|
John Zimmer
Angel
|
1 | United States, Switzerland | Series B, Seed | Mining, FinTech, Mineral | |
|
Feike Sijbesma
Angel
|
1 | Switzerland | Seed | Biotechnology, Product Research | |
|
Walter Fischl
Angel
|
1 | Switzerland | Medical, Health Care, Biotechnology | ||
|
Nicolas Mermod
Angel
|
1 | Switzerland | Series A | Health Care, Biotechnology, Science and Engineering | |
|
Arda Kara
Angel
|
1 | United States, Germany, Switzerland | Series A, Seed, Series B | Health Care, Medical, Software | $25M–$27M |
|
Thorsten Schroeder
Angel
|
1 | United States, Brazil, Switzerland | Seed, Series B | Electronics, Children, Life Science | $18M–$23M |
|
Lukas Speiser
Angel
|
1 | Germany, Switzerland | Seed | Wellness, Nutrition, Health Care | |
| Access all 19 angel investors in Switzerland Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Industry: Health Care, Medical, Finance
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $533k–$8.9M; Series A $1.1M–$6.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Beat Schillig - Founder @ Venture Kick
Show more...Investment focus
- Industry: Information Technology, SaaS, Music
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 3
- Round size: Seed $2.2M–$5.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
- PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
- 1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.
Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.
Show more...Investment focus
- Industry: Robotics, Neuroscience
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.
Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.
Show more...Investment focus
- Industry: Security, Wireless, Wearables
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Biowatch — Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matchingtheir vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords.Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.
Reinhard Ambros
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland
Investor stats
- Total investments: 11
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- FORMA Therapeutics — Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
- Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Ulf Claesson
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment
Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 8
- Round size: Seed $250k–$2.9M; Series A $2.1M–$24M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
- Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
- Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.
As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.
Show more...Investment focus
- Industry: Biotechnology, Product Research
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
John Zimmer is the co-founder and President of Lyft, the on-demand ridesharing platform, that was founded in 2007 with Zimride as its first of two products built to create a more social, sustainable and affordable transportation system. John’s interest in peer-to-peer transportation began at Cornell’s School of Hotel Administration. Uponlearning that only 20% of seats in cars on highways are occupied, he began working on ways to use existing information infrastructures to solve the problem of unused empty seats. After graduating first in his class, John spent two years at Lehman Brothers before (luckily) leaving to rideshare his way from New York to San Francisco to join co-founder Logan Green in launching Zimride. John was recognized in 2009 as one of Businessweek's Top 25 Entrepreneurs Under 25, and has spoken at top tier events such as SXSW, The Association for Commuter Transportation (ACT) International Conference and Stanford Business School. With Lyft, John hopes to fix the current state of transportation across the country, and eventually around the world, to make cities safer, more affordable and better connected. Since unveiling the product in June 2012, Lyft has quickly become one of the fastest-growing tech companies with more than $80 million raised from leading investors Andreessen Horowitz and Founders Fund and has been featured in The Economist, the New York Times and on NBC’s TODAY Show. Lyft is currently available in San Francisco, Los Angeles, Seattle, San Diego, Chicago, Boston and Washington, D.C., with more than a million rides shared on the platform to date.
Show more...Investment focus
- Industry: Mining, FinTech, Mineral
- Stage:Series B, Seed
- Geography: United States, Switzerland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Deel — With Deel, your business can easily hire anywhere. No more worrying about local laws, complex tax systems, or managing international payroll. Deel takes care of everything in 150+ countries.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- KoBold Metals — KoBold is a mineral exploration company driving the clean energy future by accelerating the discovery of critical metals.
Feike has been the CEO and Chairman of the Managing Board of Directors of Royal DSM N.V. (a global Life Sciences and Materials Sciences company) since May 2007. In 1995, Feike became director of Gist-Brocades Food Specialties Division and joined Gist-Brocade’s executive committee. Following the acquisition by Royal DSM N.V. in 1998, he became adirector of the business group DSM Food Specialties. In 2000 he joined Royal DSM’s managing board of directors, becoming Chairman and CEO in May 2007.He is currently a member of the supervisory board of De Nederlandsche Bank (DNB, the Dutch Central Bank), and a board member of CEFIC (European Chemical Industry Council) and member of the Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).His previous roles have included member of the Supervisory Board of DSM Netherlands, the Utrecht University, the Dutch Genomics Initiative (NGI) and the Anthonie van Leeuwenhoek Hospital/Netherlands Cancer Institute (NKI/AVL), chairman of Chemical Governors and a Global Agenda Council of the World Economic Forum, Dutch Food Chain Sustainability Foundation (DUVO) and of EuropaBio (European Biotech Association), a member of the Dutch Innovation Platform 2.0, board member of BIO (US Biotechnology Association), the Swiss Society of Chemical Industries (SCGI) and the Dutch Nutrition/Food Top-Institute (WCFS) and a member of the advisory board of ECP-EPN (e-commerce) and the Rotterdam Business School of the Erasmus University.
Show more...Investment focus
- Industry: Biotechnology, Product Research
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Walter Fischl
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- ProteoMediX — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
Nicolas Mermod
Show more...Investment focus
- Industry: Health Care, Biotechnology, Science and Engineering
- Stage:Series A
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
Arda Kara
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 9
- Round size: Series A $25M–$27M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
- Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
- Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Thorsten Schroeder
Show more...Investment focus
- Industry: Electronics, Children, Life Science
- Stage:Seed, Series B
- Geography: United States, Brazil, Switzerland
Investor stats
- Total investments: 9
- Round size: Series B $18M–$23M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
- TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
- 4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.
Lukas Speiser is the founder and CEO of Amorana.ch
Show more...Investment focus
- Industry: Wellness, Nutrition, Health Care
- Stage:Seed
- Geography: Germany, Switzerland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.
- Testmate Health — Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home.
Biotechnology Angel investor funding in Switzerland at a glance
Stats across 17 deals from 19 investors.
Access all 19 angel investors in Switzerland Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 19 angel investors investing in Switzerland Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!